These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 14967110

  • 1. [Intervention program to improve secondary prevention of myocardial infarction. Results of the PRESENTE (early secondary prevention) study].
    de Velasco JA, Cosín J, de Oya M, de Teresa E, Grupo de investigadores del estudio PRESENTE.
    Rev Esp Cardiol; 2004 Feb; 57(2):146-54. PubMed ID: 14967110
    [Abstract] [Full Text] [Related]

  • 2. [Reduction of in-hospital mortality and improved secondary prevention after acute myocardial infarction. First results from the registry of secondary prevention after acute myocardial infarction (SAMI)].
    Tebbe U, Messer C, Stammwitz E, The GS, Dietl J, Bischoff KO, Schulten-Baumer U, Tebbenjohanns J, Gohlke H, Bramlage P, SAMI Studiengruppe.
    Dtsch Med Wochenschr; 2007 Jul 30; 132(30):1559-66. PubMed ID: 17628839
    [Abstract] [Full Text] [Related]

  • 3. [Secondary prevention of myocardial infarction in Spain. The PREVERSE study].
    de Velasco JA, Cosín J, López Sendón JL, de Teresa E, de Oya M, Carrasco JL, Navarro A.
    Rev Esp Cardiol; 1997 Jun 30; 50(6):406-15. PubMed ID: 9304163
    [Abstract] [Full Text] [Related]

  • 4. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis.
    van der Elst ME, Bouvy ML, de Blaey CJ, de Boer A.
    Clin Ther; 2005 Nov 30; 27(11):1806-14. PubMed ID: 16368451
    [Abstract] [Full Text] [Related]

  • 5. [Cracovian program for secondary prevention of ischemic heart disease. Secondary prevention of ischemic heart disease during hospitalization in 1996-97 and 1998-99].
    Pajak A, Kawecka-Jaszcz K, Jankowski P, Bilo G, Dubiel JS, Maciejewicz J, Piotrowski W, Smielak-Korombel W, Tracz W.
    Przegl Lek; 2003 Nov 30; 60(3):136-41. PubMed ID: 14575013
    [Abstract] [Full Text] [Related]

  • 6. [Cracovian program for secondary prevention of ischemic heart disease. Secondary prevention of ischemic heart disease after discharge in 1997-98 and 1999-2000].
    Jankowski P, Kawecka-Jaszcz K, Pajak A, Bilo G, Dubiel JS, Maciejewicz J, Piotrowski W, Smielak-Korombel W, Tracz W.
    Przegl Lek; 2003 Nov 30; 60(3):142-6. PubMed ID: 14575014
    [Abstract] [Full Text] [Related]

  • 7. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
    Gasse C, Jacobsen J, Larsen AC, Schmidt EB, Johannesen NL, Videbaek J, Sørensen HT, Johnsen SP.
    Eur J Vasc Endovasc Surg; 2008 Jan 30; 35(1):51-8. PubMed ID: 17923426
    [Abstract] [Full Text] [Related]

  • 8. Treatment with statins after acute myocardial infarction in patients >or=80 years: underuse despite general acceptance of drug therapy for secondary prevention.
    Kvan E, Pettersen KI, Landmark K, Reikvam A, INPHARM study investigators.
    Pharmacoepidemiol Drug Saf; 2006 Apr 30; 15(4):261-7. PubMed ID: 16315337
    [Abstract] [Full Text] [Related]

  • 9. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS, Bajorek BV.
    J Clin Pharm Ther; 2008 Dec 30; 33(6):591-601. PubMed ID: 19138236
    [Abstract] [Full Text] [Related]

  • 10. [Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part III. Secondary prevention of ischaemic heart disease after discharge].
    Kawecka-Jaszcz K, Jankowski P, Pajak A, Dubiel J, Maciejewicz J, Piotrowski W, Smielak-Korombel W, Tracz W.
    Przegl Lek; 2001 Dec 30; 58(11):964-8. PubMed ID: 11987836
    [Abstract] [Full Text] [Related]

  • 11. Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?
    Wachtel TM, Kucia AM, Greenhill JA.
    Rural Remote Health; 2008 Dec 30; 8(4):967. PubMed ID: 18855517
    [Abstract] [Full Text] [Related]

  • 12. [Secondary prevention in outpatients with coronary artery disease. Adherence with recommendations within 4 weeks after hospital discharge].
    Zeymer U, ATKA-Register-Teilnehmer.
    Dtsch Med Wochenschr; 2007 Nov 30; 132(45):2367-70. PubMed ID: 17972241
    [Abstract] [Full Text] [Related]

  • 13. Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population.
    Fernandes AW, Madhavan SS, Amonkar MM.
    Clin Ther; 2005 May 30; 27(5):630-45. PubMed ID: 15978313
    [Abstract] [Full Text] [Related]

  • 14. Achievement of secondary preventive goals after acute myocardial infarction: a comparison between participants and nonparticipants in a routine patient education program in Sweden.
    Bellman C, Hambraeus K, Lindbäck J, Lindahl B.
    J Cardiovasc Nurs; 2009 May 30; 24(5):362-8. PubMed ID: 19652617
    [Abstract] [Full Text] [Related]

  • 15. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
    Goyal A, Alexander JH, Hafley GE, Graham SH, Mehta RH, Mack MJ, Wolf RK, Cohn LH, Kouchoukos NT, Harrington RA, Gennevois D, Gibson CM, Califf RM, Ferguson TB, Peterson ED, PREVENT IV Investigators.
    Ann Thorac Surg; 2007 Mar 30; 83(3):993-1001. PubMed ID: 17307447
    [Abstract] [Full Text] [Related]

  • 16. Does a telephone follow-up intervention for patients discharged with acute myocardial infarction have long-term effects on health-related quality of life? A randomised controlled trial.
    Hanssen TA, Nordrehaug JE, Eide GE, Hanestad BR.
    J Clin Nurs; 2009 May 30; 18(9):1334-45. PubMed ID: 19220616
    [Abstract] [Full Text] [Related]

  • 17. Is angiotensin-converting enzyme inhibitor useful in a Japanese population for secondary prevention after acute myocardial infarction? A final report of the Japanese Acute Myocardial Infarction Prospective (JAMP) study.
    Ueshima K, Fukami K, Hiramori K, Hosoda S, Kishida H, Kato K, Fujita T, Tsutani K, Sakuma A, Japanese Acute Myocardial Infarction Prospective study group.
    Am Heart J; 2004 Aug 30; 148(2):e8. PubMed ID: 15309011
    [Abstract] [Full Text] [Related]

  • 18. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC, Tu JV, Ko DT, Alter DA.
    CMAJ; 2008 Oct 21; 179(9):901-8. PubMed ID: 18936455
    [Abstract] [Full Text] [Related]

  • 19. Impact of an educational intervention for secondary prevention of myocardial infarction on Medicaid drug use and cost.
    Zuckerman IH, Weiss SR, McNally D, Layne B, Mullins CD, Wang J.
    Am J Manag Care; 2004 Jul 21; 10(7 Pt 2):493-500. PubMed ID: 15298236
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.